{"id":98,"date":"2026-02-12T12:18:21","date_gmt":"2026-02-12T11:18:21","guid":{"rendered":"https:\/\/www.doctaforum-events.org\/2026\/sogug2026\/?page_id=98"},"modified":"2026-10-13T15:05:44","modified_gmt":"2026-10-13T13:05:44","slug":"miercoles-18-de-noviembre","status":"publish","type":"page","link":"https:\/\/www.doctaforum-events.org\/2026\/sogug2026\/programa\/miercoles-18-de-noviembre\/","title":{"rendered":"Miercoles, 18 de Noviembre"},"content":{"rendered":"
\r\n\r\n\t
\r\n\t\t
\r\n\t\t\t12:00 – 12:30<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\tActo inaugural \/ Opening ceremony<\/i><\/span>\r\n\t\t\t
\r\n\t\t\t\tDra. Ar\u00e1nzazu Gonz\u00e1lez del Alba Baamonde<\/span>\r\n\t\t\t\tPresidenta de SOGUG, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid<\/span>\r\n\t\t\t<\/div>\r\n\t\t\t
\r\n\t\t\t\tDr. Sergio V\u00e1zquez Est\u00e9vez<\/span>\r\n\t\t\t\tVicepresidente de SOGUG, Hospital Universitario Lucus Augusti, Lugo<\/span>\r\n\t\t\t<\/div>\r\n\t\t\t
\r\n\t\t\t\tSr. Ram\u00f3n Reyes Bori<\/span>\r\n\t\t\t\tPresidente de la Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer AECC<\/span>\r\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n\r\n\t
\r\n\t\t
\r\n\t\t\t12:30 – 13:55<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\tINVESTIGACI\u00d3N TRASLACIONAL EN TUMORES GENITOURINARIOS<\/span>\r\n\t\t\tTRANSLATIONAL RESEARCH IN GENITOURINARY TUMORS<\/i><\/span>\r\n\t\t<\/div>\r\n\t<\/div>\r\n\r\n\t
\r\n\t\t
\r\n\t\t\tModeradores:<\/span>\r\n\t\t\t
\r\n\t\t\tChairs:<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\t
\r\n\t\t\t\tDr. Eneko Novo Sukia<\/span>\r\n\t\t\t\tHospital Universitario de Cruces, Barakaldo<\/span>\r\n\t\t\t<\/div>\r\n\t\t\t
\r\n\t\t\t\tDra. Caroline Elisabeth Nunes-Xavier<\/span>\r\n\t\t\t\tOslo University Hospital, Oslo, Noruega<\/span>\r\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n\r\n\t
\r\n\t\t
\r\n\t\t\t12:30 – 12:40<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\tDeterminantes de respuesta y resistencia a la inmunoterapia en tumores genitourinarios: una visi\u00f3n traslacional integradora<\/span>\r\n\t\t\tDeterminants of response and resistance to immunotherapy in genitourinary tumors: an integrative translational perspective<\/span>\r\n\t\t\t
\r\n\t\t\t\tDr. Larry Fong<\/span>\r\n\t\t\t\tFred Hutchinson Cancer Center, Seattle, EE.UU.<\/span>\r\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n\r\n\t
\r\n\t\t
\r\n\t\t\t12:40 – 12:50<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\tCaracterizaci\u00f3n de los cambios evolutivos en el tumor y el microambiente tumoral en muestras de tumores renales primarios y met\u00e1stasis metacr\u00f3nicas pareadas<\/span>\r\n\t\t\tCharacterization of evolutionary changes in the tumor and tumor microenvironment in paired primary renal tumor samples and metachronous metastases<\/span>\r\n\t\t\t
\r\n\t\t\t\tDr. Jos\u00e9 Luis P\u00e9rez Gracia<\/span>\r\n\t\t\t\tCl\u00ednica Universidad de Navarra, Pamplona<\/span>\r\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n\r\n\t
\r\n\t\t
\r\n\t\t\t12:50 – 13:00<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\tBiopsia l\u00edquida en carcinoma renal avanzado: detecci\u00f3n ultrasensible de ctDNA y aclaramiento molecular como biomarcador pron\u00f3stico y predictivo en la era de la inmunoterapia<\/span>\r\n\t\t\tLiquid biopsy in advanced renal cell carcinoma: ultrasensitive ctDNA detection and molecular clearance as a prognostic and predictive biomarker in the immunotherapy era<\/span>\r\n\t\t\t
\r\n\t\t\t\tDr. Juan Ruiz-Ba\u00f1obre<\/span>\r\n\t\t\t\tHospital Cl\u00ednico Universitario de Santiago de Compostela<\/span>\r\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n\r\n\t
\r\n\t\t
\r\n\t\t\t13:00 – 13:10<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\tPerfil inmunol\u00f3gico en c\u00e1ncer de pr\u00f3stata: de la caracterizaci\u00f3n del microambiente inmune a la selecci\u00f3n de pacientes para inmunoterapia<\/span>\r\n\t\t\tImmune profiling in prostate cancer: from characterization of the immune microenvironment to patient selection for immunotherapy<\/span>\r\n\t\t\t
\r\n\t\t\t\tDra. Nuria Romero Laorden<\/span>\r\n\t\t\t\tHospital Universitario La Princesa, Madrid<\/span>\r\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n\r\n\t
\r\n\t\t
\r\n\t\t\t13:10 – 13:55<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\tDiscusi\u00f3n \/ Discussion<\/i><\/span>\r\n\t\t<\/div>\r\n\t<\/div>\r\n\r\n\t
\r\n\t\t
\r\n\t\t\t14:00 – 15:15<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\tSIMPOSIO SAT\u00c9LITE<\/strong><\/span>\r\n\t\t\t
\r\n\t\t\tSATELLITE SYMPOSIUM<\/span>\r\n\t\t<\/div>\r\n\t<\/div>\r\n\t
\r\n\t\t
\r\n\t\t\t<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\t
\r\n\t\t\t\tSala Roma<\/span>\r\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n\r\n<\/div>\r\n\r\n
\r\n\r\n\t
\r\n\t\t
\r\n\t\t\t15:30 – 17:15<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\tMESA 1<\/strong> ENFERMEDAD LOCALIZADA<\/span>\r\n\t\t\t
\r\n\t\t\tSESSION 1<\/strong> LOCALIZED DISEASE<\/span>\r\n\t\t<\/div>\r\n\t<\/div>\r\n\r\n\t
\r\n\t\t
\r\n\t\t\tModeradores:<\/span>\r\n\t\t\t
\r\n\t\t\tChairs:<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\t
\r\n\t\t\t\tDra. Ar\u00e1nzazu Gonz\u00e1lez del Alba<\/span>\r\n\t\t\t\tPresidenta de SOGUG, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid<\/span>\r\n\t\t\t<\/div>\r\n\t\t\t
\r\n\t\t\t\tDr. Alfredo Rodr\u00edguez-Antol\u00edn<\/span>\r\n\t\t\t\tHospital Universitario 12 de Octubre, Madrid<\/span>\r\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n\r\n\t
\r\n\t\t
\r\n\t\t\t15:30 – 16:00<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\tSesi\u00f3n de controversia: manejo del c\u00e1ncer de pr\u00f3stata de alto riesgo<\/span>\r\n\t\t\tControversy session: management of high-risk prostate cancer<\/span>\r\n\r\n\t\t\t
\r\n\t\t\t\t
\r\n\t\t\t\t\t15:30 – 15:45<\/span>\r\n\t\t\t\t<\/div>\r\n\t\t\t\t
\r\n\t\t\t\t\t\u00bfEs la prostatectom\u00eda radical junto con el tratamiento hormonal perioperatorio un nuevo est\u00e1ndar?<\/span>\r\n\t\t\t\t\tIs radical prostatectomy combined with perioperative hormonal therapy a new standard?<\/span>\r\n\t\t\t\t\t
\r\n\t\t\t\t\t\tDra. Sara Mart\u00ednez Breijo<\/span>\r\n\t\t\t\t\t\tComplexo Hospitalario Universitario de A Coru\u00f1a<\/span>\r\n\t\t\t\t\t<\/div>\r\n\t\t\t\t<\/div>\r\n\t\t\t<\/div>\r\n\r\n\t\t\t
\r\n\t\t\t\t
\r\n\t\t\t\t\t15:45 – 16:00<\/span>\r\n\t\t\t\t<\/div>\r\n\t\t\t\t
\r\n\t\t\t\t\t\u00bfSigue siendo la radioterapia y la intensificaci\u00f3n hormonal el est\u00e1ndar de tratamiento?<\/span>\r\n\t\t\t\t\tAre radiotherapy and hormonal intensification still the standard of care?<\/span>\r\n\t\t\t\t\t
\r\n\t\t\t\t\t\tDr. Fernando L\u00f3pez Campos<\/span>\r\n\t\t\t\t\t\tHospital Universitario Ram\u00f3n y Cajal, Madrid<\/span>\r\n\t\t\t\t\t<\/div>\r\n\t\t\t\t<\/div>\r\n\t\t\t<\/div>\r\n\r\n\t\t<\/div>\r\n\t<\/div>\r\n\r\n\t
\r\n\t\t
\r\n\t\t\t16:00 – 16:15<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\tTratamiento de la recidiva bioqu\u00edmica y la persistencia de PSA tras tratamiento radical<\/span>\r\n\t\t\tManagement of Biochemical Recurrence and Persistent PSA after Radical Treatment<\/span>\r\n\t\t\t
\r\n\t\t\t\tTBC<\/span>\r\n\t\t\t\t<\/span>\r\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n\r\n\t
\r\n\t\t
\r\n\t\t\t16:15 – 16:30<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\t\u00bfCu\u00e1l es el rol del PSMA-PET en la pr\u00e1ctica cl\u00ednica? \u00bfC\u00f3mo interpretar bien un informe de PET?<\/span>\r\n\t\t\tWhat is the role of PSMA-PET in clinical practice? How should a PET report be correctly interpreted?<\/span>\r\n\t\t\t
\r\n\t\t\t\tDra. Macarena Rodr\u00edguez Fraile<\/span>\r\n\t\t\t\tCl\u00ednica Universidad de Navarra, Pamplona<\/span>\r\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n\r\n\t
\r\n\t\t
\r\n\t\t\t16:30 – 17:15<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\tDiscusi\u00f3n \/ Discussion<\/i><\/span>\r\n\t\t<\/div>\r\n\t<\/div>\r\n\r\n\t
\r\n\t\t
\r\n\t\t\t17:15 – 17:45<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\tCaf\u00e9 \/ Coffee<\/i><\/span>\r\n\t\t<\/div>\r\n\t<\/div>\r\n\r\n\t
\r\n\t\t
\r\n\t\t\t17:45 – 19:30<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\tMESA 2<\/strong> C\u00c1NCER DE PR\u00d3STATA METAST\u00c1SICO<\/span>\r\n\t\t\t
\r\n\t\t\tSESSION 2<\/strong> METASTATIC PROSTATE CANCER<\/span>\r\n\t\t<\/div>\r\n\t<\/div>\r\n\r\n\t
\r\n\t\t
\r\n\t\t\tModeradores:<\/span>\r\n\t\t\t
\r\n\t\t\tChairs:<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\t
\r\n\t\t\t\tDr. Enrique Gallardo D\u00edaz<\/span>\r\n\t\t\t\tHospital Universitari Parc Taul\u00ed, Sabadell<\/span>\r\n\t\t\t<\/div>\r\n\t\t\t
\r\n\t\t\t\tDra. Bego\u00f1a Mellado Gonz\u00e1lez<\/span>\r\n\t\t\t\tHospital Cl\u00ednic de Barcelona<\/span>\r\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n\r\n\t
\r\n\t\t
\r\n\t\t\t17:45 – 18:00<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\tPerfilando el paciente con c\u00e1ncer de pr\u00f3stata sensible a castraci\u00f3n metast\u00e1sico (CPSCm) para optimizaci\u00f3n terap\u00e9utica<\/span>\r\n\t\t\tProfiling the patient with metastatic castration-sensitive prostate cancer (mCSPC) for therapeutic optimization<\/span>\r\n\t\t\t
\r\n\t\t\t\tDr. Karim Fizazi<\/span>\r\n\t\t\t\tCentre Oscar Lambret, Lille, Francia<\/span>\r\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n\r\n\t
\r\n\t\t
\r\n\t\t\t18:00 – 18:15<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\tNovedades en el tratamiento y la evaluaci\u00f3n del paciente con c\u00e1ncer de pr\u00f3stata resistente a castraci\u00f3n (CPRC): \u00bfc\u00f3mo implementamos las gu\u00edas PCWG4 en la pr\u00e1ctica cl\u00ednica?<\/span>\r\n\t\t\tAdvances in the treatment and assessment of patients with castration-resistant prostate cancer (CRPC): how do we implement the PCWG4 guidelines in clinical practice?<\/span>\r\n\t\t\t
\r\n\t\t\t\tDr. Charles Ryan<\/span>\r\n\t\t\t\tMemorial Sloan Kettering Cancer Center, Nueva York, EE.UU.<\/span>\r\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n\r\n\t
\r\n\t\t
\r\n\t\t\t18:15 – 18:30<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\tNuevas estrategias en investigaci\u00f3n en la enfermedad avanzada<\/span>\r\n\t\t\tNew research strategies in advanced disease<\/span>\r\n\t\t\t
\r\n\t\t\t\tDr. David Lorente Estell\u00e9s<\/span>\r\n\t\t\t\tInstituto Valenciano de Oncolog\u00eda, Valencia<\/span>\r\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n\r\n\t
\r\n\t\t
\r\n\t\t\t18:30 – 18:45<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\tC\u00f3mo optimizar la calidad de vida del paciente con c\u00e1ncer de pr\u00f3stata avanzado<\/span>\r\n\t\t\tHow to optimize quality of life in patients with advanced prostate cancer<\/span>\r\n\t\t\t
\r\n\t\t\t\tDr. Enrique Gallardo D\u00edaz<\/span>\r\n\t\t\t\tHospital Universitari Parc Taul\u00ed, Sabadell<\/span>\r\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n\r\n\t
\r\n\t\t
\r\n\t\t\t18:45 – 19:30<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\tDiscusi\u00f3n \/ Discussion<\/i><\/span>\r\n\t\t<\/div>\r\n\t<\/div>\r\n\r\n\t
\r\n\t\t
\r\n\t\t\t21:00<\/span>\r\n\t\t<\/div>\r\n\t\t
\r\n\t\t\tCena Simposio Especial \/ Special Symposium Dinner<\/i><\/span>\r\n\t\t<\/div>\r\n\t<\/div>\r\n\r\n<\/div>","protected":false},"excerpt":{"rendered":"12:00 – 12:30 Acto inaugural \/ Opening ceremony Dra. Ar\u00e1nzazu Gonz\u00e1lez del Alba Baamonde Presidenta de SOGUG, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid Dr. Sergio V\u00e1zquez Est\u00e9vez Vicepresidente de SOGUG, Hospital Universitario Lucus Augusti, Lugo Sr. Ram\u00f3n Reyes Bori Presidente de la Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer AECC 12:30 – 13:55 INVESTIGACI\u00d3N TRASLACIONAL EN … Leer m\u00e1s<\/a>","protected":false},"author":2,"featured_media":0,"parent":45,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"template-internas.php","meta":{"footnotes":""},"class_list":["post-98","page","type-page","status-publish"],"_links":{"self":[{"href":"https:\/\/www.doctaforum-events.org\/2026\/sogug2026\/wp-json\/wp\/v2\/pages\/98","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.doctaforum-events.org\/2026\/sogug2026\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.doctaforum-events.org\/2026\/sogug2026\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.doctaforum-events.org\/2026\/sogug2026\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.doctaforum-events.org\/2026\/sogug2026\/wp-json\/wp\/v2\/comments?post=98"}],"version-history":[{"count":14,"href":"https:\/\/www.doctaforum-events.org\/2026\/sogug2026\/wp-json\/wp\/v2\/pages\/98\/revisions"}],"predecessor-version":[{"id":217,"href":"https:\/\/www.doctaforum-events.org\/2026\/sogug2026\/wp-json\/wp\/v2\/pages\/98\/revisions\/217"}],"up":[{"embeddable":true,"href":"https:\/\/www.doctaforum-events.org\/2026\/sogug2026\/wp-json\/wp\/v2\/pages\/45"}],"wp:attachment":[{"href":"https:\/\/www.doctaforum-events.org\/2026\/sogug2026\/wp-json\/wp\/v2\/media?parent=98"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}